CSG Stock Under Pressure as UBS Lists Bearish Warrants and NATO Orders Fail to Lift Sentiment

CSG shares plunge 13.68% on week to €15.60 amid UBS launch of turbo put warrants, even as company posts 72% revenue surge and €17B backlog.

The Czechoslovak Group has landed a fresh contract to supply advanced munition fuses to two NATO member states, worth a high double-digit million euro sum. The Czech defence company will manufacture the hardware through its European production network spanning Italy, Spain and the UK, replenishing alliance stockpiles to strict NATO specifications. The buyer identities remain undisclosed. Yet the positive news failed to stem a sharp sell-off in CSG shares, which closed at €15.60 – down 13.68% on the week and far below the January peak of €36.05.

Against this backdrop, UBS has introduced a new instrument that allows traders to bet directly against CSG stock. On 2 June 2026, the bank launched up to 10 million open-end turbo put warrants on CSG N.V., listed on Euronext Amsterdam. The product carries an initial strike price of €18.70, an identical knock-out barrier at €18.70, and an issue price of €0.17. With a multiplier of 10:1 (0.10), the warrant is designed for short-term directional plays and offers no capital protection. The offer is open in Germany, Austria and Luxembourg.

UBS stressed that the proceeds serve the group’s general funding needs and do not flow to CSG or finance any defence, munitions or aerospace activities. The timing coincides with extreme volatility: the 30-day annualised volatility in CSG shares has hit 80.26%. Whether the warrant is used for hedging, tactical trading or outright bearish positioning remains unclear, as the bank did not specify a trigger for the issuance.

Meanwhile, CSG’s underlying business continues to fire on all cylinders. For the 2025 financial year, revenue surged roughly 72% to €6.7 billion, driven by the acquisition of Kinetic Group and robust global defence demand. The order book is well filled: at the end of March 2026, the backlog stood at €17 billion, and first-quarter 2026 revenue reached €1.544 billion – a 13.8% year-on-year advance. Management reaffirmed its 2026 guidance of up to €7.6 billion in sales and a stable adjusted operating margin of around 24%, with large-calibre ammunition and land systems remaining the key revenue drivers.

The conflicting signals – a strong operational story and a new, overtly bearish derivative product – have left CSG shares locked in a downward trend. The stock now trades at roughly €15.60, more than 56% below the year’s high. Investors appear to be looking past the contract wins and instead focusing on the broader sector rotation and geopolitical uncertainty that have weighed on European defence names.

CSG’s next catalyst is the release of its half-year results, scheduled for early August. The company has published conflicting dates – one statement points to 6 August, another to 7 August 2026 – for the report covering the period through 30 June. Until then, the market must weigh a record order backlog and steady margin performance against a derivative tool that explicitly profits from further declines.